In addition to SCA1, ATXN1 has been implicated in various neurological disorders, such as Alzheimer’s disease [7] and multiple sclerosis [8], as well as in cancer [9,10]. This evidence concerns the gene ATXN1 and early-onset autosomal dominant Alzheimer disease.